Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database EClinicalMedicine. 2024 Oct; 76:102811. . View in PubMed

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D JCO Precis Oncol. 2024 Sep; 8:e2400258. . View in PubMed

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I) JCO Precis Oncol. 2024 Sep; 8:e2400418. . View in PubMed

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G Oncologist. 2024 Aug 05; 29(8):723-e1093. . View in PubMed

Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial Oncologist. 2024 Jul 05; 29(7):638-e952. . View in PubMed

Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial JCO Precis Oncol. 2024 Jun; 8:e2400103. . View in PubMed

A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastomaA Children's Oncology Group study (COG ARET12P1). Pediatr Blood Cancer. 2024 Jan; 71(1):e30718. . View in PubMed

Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective EJC Paediatr Oncol. 2023 Dec; 2. . View in PubMed

Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range Res Sq. 2023 Mar 21. . View in PubMed

Children's Oncology Group's 2023 blueprint for research: Rare tumors Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30574. . View in PubMed

Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee Pediatr Blood Cancer. 2023 07; 70(7):e30365. . View in PubMed

Refining the serum miR-371a-3p test for viable germ cell tumor detection Sci Rep. 2023 06 29; 13(1):10558. . View in PubMed

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C J Natl Cancer Inst. 2023 11 08; 115(11):1355-1363. . View in PubMed

Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731 J Pediatr Surg. 2022 Oct; 57(10):251-256. . View in PubMed

EMBRACE: An EM-based bias reduction approach through Copas-model estimation for quantifying the evidence of selective publishing in network meta-analysis Biometrics. 2022 06; 78(2):754-765. . View in PubMed

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321) J Clin Oncol. 2022 11 20; 40(33):3839-3847. . View in PubMed

Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee J Clin Oncol. 2022 02 10; 40(5):459-467. . View in PubMed

Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study Cancer. 2022 03 01; 128(5):1057-1065. . View in PubMed

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial J Clin Oncol. 2022 07 10; 40(20):2235-2245. . View in PubMed

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial J Clin Oncol. 2022 07 10; 40(20):2224-2234. . View in PubMed

Semiparametric isotonic regression modelling and estimation for group testing data Can J Stat. 2021 Sep; 49(3):659-677. . View in PubMed

Imaging Appearance of Nongerminoma Pediatric Ovarian Germ Cell Tumors Does Not Discriminate Benign from Malignant Histology J Pediatr Adolesc Gynecol. 2021 Jun; 34(3):383-386. . View in PubMed

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis Clin Genitourin Cancer. 2021 12; 19(6):469-479. . View in PubMed

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee J Pediatr Surg. 2020 Apr; 55(4):655-659. . View in PubMed

A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231) Pediatr Blood Cancer. 2020 09; 67(9):e28502. . View in PubMed

The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database Pediatr Blood Cancer. 2020 08; 67(8):e28350. . View in PubMed

Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features Mod Pathol. 2020 03; 33(3):496-513. . View in PubMed

Response adaptive randomization procedures in seamless phase II/III clinical trials J Biopharm Stat. 2020; 30(1):3-17. . View in PubMed

Copas-like selection model to correct publication bias in systematic review of diagnostic test studies Stat Methods Med Res. 2019 Oct-Nov; 28(10-11):2912-2923. . View in PubMed

Semiparametric Model for Bivariate Survival Data Subject to Biased Sampling J R Stat Soc Series B Stat Methodol. 2019 Apr; 81(2):409-429. . View in PubMed

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study J Clin Oncol. 2019 11 01; 37(31):2883-2891. . View in PubMed

Trial Design Challenges and Approaches for Precision Oncology in Rare Tumors: Experiences of the Children's Oncology Group JCO Precis Oncol. 2019; 3. . View in PubMed

Efficient two-stage designs and proper inference for animal studies Stat Biosci. 2018 Apr; 10(1):217-232. . View in PubMed

Genetic heterogeneity of uncharacterized childhood autoimmune diseases with lymphoproliferation Pediatr Blood Cancer. 2018 Feb; 65(2). . View in PubMed

Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R Am J Hematol. 2018 10; 93(10):1245-1253. . View in PubMed

Semiparametric model and inference for spontaneous abortion data with a cured proportion and biased sampling Biostatistics. 2018 01 01; 19(1):54-70. . View in PubMed

Estimating the ratio of multivariate recurrent event rates with application to a blood transfusion study Stat Methods Med Res. 2017 Aug; 26(4):1969-1981. . View in PubMed

Maximum likelihood estimation and EM algorithm of Copas-like selection model for publication bias correction Biostatistics. 2017 Jul 01; 18(3):495-504. . View in PubMed

Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases Clin Cancer Res. 2017 04 15; 23(8):2093-2104. . View in PubMed

Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells Cancer Lett. 2017 02 01; 386:131-140. . View in PubMed

A joint latent class analysis for adjusting survival bias with application to a trauma transfusion study Stat Med. 2016 Jan 15; 35(1):65-77. . View in PubMed

B7-H4 expression in ovarian serous carcinoma: a study of 306 cases Hum Pathol. 2016 11; 57:1-6. . View in PubMed

Recurrent event frailty models reduced time-varying and other biases in evaluating transfusion protocols for traumatic hemorrhageJ Clin Epidemiol. 2016 09; 77:52-59. e1. . View in PubMed

A joint latent class model for classifying severely hemorrhaging trauma patients BMC Res Notes. 2015 Oct 24; 8:602. . View in PubMed

ATM-dependent DNA damage-response pathway as a determinant in chronic myelogenous leukemia DNA Repair (Amst). 2013 Jul; 12(7):500-7. . View in PubMed